The appeal of leveraging both pharmaceutical precision and natural vitality is understandable, yet it also introduces complexities and important considerations that demand careful attention
At first glance, it may seem like higher oral doses would work better, but evidence suggests that is not always true
GLP-1 is a well established regulator of appetite and metabolism
The therapeutic potential of MSC-Exos in disorders caused by ferroptosis is further underscored by their effectiveness in reducing oxidative stress, decreasing lipid peroxidation, and inhibiting ferroptotic cell death [12, 13]
acidic peptides may need a mildly basic one
The NRF2/FPN1 signalling pathway can inhibit ferroptosis by regulating iron metabolism homeostasis, which partially alleviates myocardial reperfusion injury in diabetes mellitus [144]